Compare ARK Genomic Revolution ETF (ARKG) vs Atmos Energy Corporation (ATO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Atmos Energy Corporation — how do they compare? ARK Genomic Revolution ETF trades at $40.45, while Atmos Energy Corporation trades at $179.55 (market cap $29.41B). The key difference: Atmos Energy Corporation pays a 2.27% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Atmos Energy Corporation nearer its low. Which is the better fit depends on your goals.
| ARKG | ATO | |
|---|---|---|
Sector | Sector/Thematic | Utilities |
52-Week High | $43.57 | $192.25 |
52-Week Low | $23.09 | $154.10 |
Market Cap | — | $29.41B |
Enterprise Value | — | $38.91B |
Dividend Yield | — | 2.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Atmos Energy (ATO) trades at $176.2, up 0.85% today, with a neutral technical signal. The stock shows strong fundamentals with revenue growth to $4.70B in 2025 and a net income margin of 27.58%. Recent Q1 2026 earnings beat expectations, and the company maintains a solid dividend. Analyst consensus is a Buy with a $189.67 price target, though technical indicators suggest near-term consolidation around key support and resistance levels.
The outlook for ATO is positive due to steady earnings growth, customer expansion, and supportive regulatory changes. Risks include high capital expenditures and exposure to energy market volatility. Institutional sentiment is bullish, with no sell ratings, positioning the stock for potential upside if operational execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Atmos Energy Corporation
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Read more on ATO →
